子痫前期染色体研究进展
摘要
子痴前期（pre—eclampsia，PE）具有遗传性特征，且和环境因素有关。在排除种族因素影响的情况下，2002年WHO估计，世界范围内PE妊娠发病率占10％，占围产期妇女死亡原因的12％；由PE或子痢产妇生下的胎儿，12％在生后一个月内死亡，而其他88％的胎儿在智力障碍或心血管相关疾病的发病率升高。PE的病因还未阐明。为了避免候选基因研究的单基因方法，人们开始了PE筛查工作。
出处
《中华围产医学杂志》
CAS
2008年第6期426-428,共3页
Chinese Journal of Perinatal Medicine
参考文献23
-
1Nilssone E, Salonen Ros H, Cnattingius S, et al. The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study. BJOG, 2004, 111:200-206.
-
2Zuluaga NA, Cuartas JM, Londono JG. Genetics of preeclampsia., an approach to genetic linkage studies. Biomedica, 2004,24:207-225.
-
3Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet, 1995,11:241-247.
-
4Arngrimsson R, Sigurdar ttir S, Frigge ML, et al. A genome-wide scan reveals a maternal susceptibility locus for preeclampsia on chromosome 2p13. Hum Mol Genet, 1999,8: 1799-1805.
-
5Laivuori H, Lahermo P, Ollikainen V, et al. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet,2003,72 : 168-177.
-
6Laasanen J, Hihunen M, Romppanen EL, et al. Microsatellite marker association at chromosome region 2p13 in Finnish patients with preeclampsia and obstetric cholestasis suggests a common risk locus. Eur J Hum Genet, 2003,11:232- 236.
-
7Fitzpatrick E, Goring HH, Liu H, et al. Fine mapping and SNP analysis of positional candidates at the preeclampsia susceptibility locus (PREG1) on chromosome 2. Hum Biol, 2004,76:849- 862.
-
8Moses EK, Fitzpatrick E, Freed KA, et al. Objective prioritization of positional candidate genes at a quantitative trait locus for preeclampsia on 2q22. Mol Hum Reprod, 2006, 12: 505-512.
-
9Harrison GA, Humphrey KE, Jones N, et al. A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. Am J Hum Genet, 1997, 60: 1158- 1167.
-
10Hayward C, Livingstone J, Holloway S, et al. An exclusion map for pre-eelampsia: assuming autosomal recessive inheritance. AmJ HumGenet, 1992,50:749-757.
-
1王敬花.2006～2008年剖宫产围手术期预防性应用抗菌药物分析[J].中国医院用药评价与分析,2009,9(11):807-808. 被引量：4
-
2张新波,陈保生.小RNA在心血管相关疾病中的功能研究及应用前景[J].中华心血管病杂志,2008,36(7):661-663. 被引量：1
-
3陈燕琳.你为什么用药效果不好？[J].大众健康,2007(12):29-29.
-
4李菊香,程晓曙.新型口服抗凝药物在心房颤动中的应用[J].中华医学信息导报,2015,0(23):18-18. 被引量：1
-
5陆清溪,石禹.药师在围产期合理用药中的指导作用[J].工企医刊,2014,27(6):1169-1170.
-
6陆基宗.围产期妇女慎用药[J].药物与人,2001,14(10):59-59.
-
7李玉珍,刘秀华,蔡莉蓉.改良的心肌微血管内皮细胞分离培养方法[J].微循环学杂志,2006,16(4):10-11. 被引量：8
-
8李娟,刘金玉.阿司匹林 致癌还是治癌?[J].健康生活,2015,0(6):20-21.
-
9吴红军,赵璐,李义霞,王会芹,胥德广,郭汲源.产后抑郁症相关心理社会因素的临床调查[J].中国妇产科临床杂志,2006,7(6):446-446. 被引量：10
-
10陆少颜,徐烨,陈泳言,潘健儿.江门市围产期妇女B族链球菌的分布情况及耐药分析[J].中文科技期刊数据库（文摘版）医药卫生,2015(4):171-173.
